- Home
- BLRX vs DTSS Comparison
BLRX vs DTSS Comparison
Compare BLRX & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- DTSS
- Stock Information
- Founded
- BLRX 2003
- DTSS 2014
- Country
- BLRX Israel
- DTSS China
- Employees
- BLRX N/A
- DTSS N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- DTSS Computer Software: Prepackaged Software
- Sector
- BLRX Health Care
- DTSS Technology
- Exchange
- BLRX Nasdaq
- DTSS Nasdaq
- Market Cap
- BLRX 17.1M
- DTSS 17.6M
- IPO Year
- BLRX 2011
- DTSS N/A
- Fundamental
- Price
- BLRX N/A
- DTSS N/A
- Analyst Decision
- BLRX Strong Buy
- DTSS
- Analyst Count
- BLRX 2
- DTSS 0
- Target Price
- BLRX $19.00
- DTSS N/A
- AVG Volume (30 Days)
- BLRX 52.2K
- DTSS 126.1K
- Earning Date
- BLRX 11-24-2025
- DTSS 11-12-2025
- Dividend Yield
- BLRX N/A
- DTSS N/A
- EPS Growth
- BLRX N/A
- DTSS N/A
- EPS
- BLRX N/A
- DTSS N/A
- Revenue
- BLRX $17,251,000.00
- DTSS $71,616,820.00
- Revenue This Year
- BLRX N/A
- DTSS N/A
- Revenue Next Year
- BLRX N/A
- DTSS N/A
- P/E Ratio
- BLRX N/A
- DTSS N/A
- Revenue Growth
- BLRX 1.19
- DTSS 198.70
- 52 Week Low
- BLRX $2.30
- DTSS $1.63
- 52 Week High
- BLRX $22.60
- DTSS $3.10
- Technical
- Relative Strength Index (RSI)
- BLRX 69.50
- DTSS 48.17
- Support Level
- BLRX $3.57
- DTSS $1.95
- Resistance Level
- BLRX $4.56
- DTSS $2.07
- Average True Range (ATR)
- BLRX 0.27
- DTSS 0.13
- MACD
- BLRX 0.08
- DTSS -0.02
- Stochastic Oscillator
- BLRX 87.13
- DTSS 23.08
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About DTSS Datasea Inc.
Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.